ASKA Pharmaceutical Holdings Co.,Ltd.

Tokyo Stock Exchange 4886.T

ASKA Pharmaceutical Holdings Co.,Ltd. EBT Margin for the year ending March 31, 2024: 15.69%

ASKA Pharmaceutical Holdings Co.,Ltd. EBT Margin is 15.69% for the year ending March 31, 2024, a 77.12% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.
  • ASKA Pharmaceutical Holdings Co.,Ltd. EBT Margin for the year ending March 31, 2023 was 8.86%, a -18.62% change year over year.
  • ASKA Pharmaceutical Holdings Co.,Ltd. EBT Margin for the year ending March 31, 2022 was 10.89%, a 68.05% change year over year.
  • ASKA Pharmaceutical Holdings Co.,Ltd. EBT Margin for the year ending March 31, 2021 was 6.48%, a 277.81% change year over year.
  • ASKA Pharmaceutical Holdings Co.,Ltd. EBT Margin for the year ending March 31, 2020 was 1.71%, a -57.47% change year over year.
Key data
Date EBT Margin Net Income Margin EBITDA Margin EBIT Margin
Market news
Loading...
Tokyo Stock Exchange: 4886.T

ASKA Pharmaceutical Holdings Co.,Ltd.

CEO Mr. Takashi Yamaguchi
IPO Date April 1, 2021
Location Japan
Headquarters 5-1, Shibaura 2-Chome
Employees 762
Sector Health Care
Industries
Description

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and manufactures, sells, imports, and exports veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.

Similar companies

4554.T

Fuji Pharma Co., Ltd.

USD 9.68

0.67%

4506.T

Sumitomo Pharma Co., Ltd.

USD 3.49

1.85%

4887.T

Sawai Group Holdings Co., Ltd.

USD 13.52

-2.38%

4569.T

KYORIN Holdings, Inc.

USD 9.17

-0.53%

4547.T

Kissei Pharmaceutical Co., Ltd.

USD 25.91

-0.18%

StockViz Staff

January 15, 2025

Any question? Send us an email